Private equity reduces patient care while enriching investors, Senate report finds
The bipartisan investigation of hospital systems purchased by Apollo Global Management and Leonard Green & Partners reinforced the findings of past academic research.
Related Articles
Use www.AirNow.gov
AirNow.gov has been moved to www.AirNow.gov You will be redirected automatically.
TO PASS S. 1828, AMENDING THE PUBLIC HEALTH SERVICE ACT … — Senate Vote #118 — Jul 7, 1971
Senate Vote #118 in 1971, in the United States Congress.
Access to Care May Reduce Cancer Disparities | SWOG
The study results are published in JAMA Network Open by a team led by Joseph Unger, PhD, a SWOG biostatistician and health services researcher at…
American Society of Clinical Oncology Policy Statement Update: The Critical Role of Phase I Trials in Cancer Research and Treatment
View all available purchase options and get full access to this article. The January 20, 2015, article by Weber et al entitled “American Society of…
Clinical research by community oncologists – PubMed
Practicing and hospital-based community oncologists are increasingly recognized as sources for clinical research activity. Although surveys have documented patients’ and physicians’ willingness to consider participation…
Ketone Metabolic Therapy – Applications, Methods, and Biomarker Monitoring – Dom D’Agostino – #CoSci
[Heads up — if you haven’t already, consider coming to Las Vegas for our very next #CoSci conference this February 8th and 9th, 2025. For…
Inside the American Airlines Campaign to Win Back Business Travelers
The nation’s second-largest carrier is playing catch-up to rivals after its bet to overhaul corporate travel failed.
Now More Than Ever, We Need to Focus on Clinical Trial Participation : Oncology Times
An abstract is unavailable.
Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology.
View all available purchase options and get full access to this article. Published in print: February 01, 1997 Published online: September 21, 2016 Request permissions…
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
PURPOSEIn patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), brentuximab vedotin (BV) as monotherapy or combined with either lenalidomide (Len) or rituximab…
